RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:443098

Hyperostosis cranialis interna

low confidenceDisorder

Publications

1,683

Trials

0

Interventional, condition-specific

Researchers

140

Distinct authors in sample

Gene link

SLC39A14

Limited

Readiness

3/6

Stages with a signal

Clinical definition (Orphanet)

A rare primary bone with increased bone density characterized by slowly endosteal hyperostosis and osteosclerosis exclusively of the skull base and the calvaria, resulting in entrapment and dysfunction of cranial nerves I, II, V, VII, and VIII. First symptoms often appear during the second decade of life and include disturbances in smell, vision, facial sensation and expression, hearing, and balance, as well as headaches due to increased ocular and intracranial pressure. After the fourth decade, radiological progression is minimal, although decreased intracranial volume can lead to death in severe cases.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (3)

hyperostosis cranalis interna · hyperostosis cranialis interna · hyperostosis cranialis interna (disease)

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.

  1. Gene identifiedPresent

    Limited — SLC39A14

  2. LiteraturePresent

    1,683 matched papers (1,382 in last 10 years) Source

  3. Phenotype characterisedPresent

    19 HPO annotations (e.g. Epiphora; Anosmia; Headache) Source

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Possibly — only limited evidence so far for SLC39A14.

GenCC classification: Limited.

Phenotypes (Monarch / HPO)

19

Associated phenotypes · MONDO:0007765

  • Epiphora
  • Anosmia
  • Headache
  • Ocular hypertension
  • Sensorineural hearing impairment

Showing 5 of 19 — open Monarch for the full list.

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

1,683

1,683 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

1,683 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

1,382 in the last 10 years · low confidence

Phrase hits: 28 · MeSH hits: 1

Open Europe PMC search

Who's working on it?

140

Distinct author names in 28 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Manni JJ11 papers · 2018

    Department of Otorhinolaryngology, Academic Hospital, Nijmegen, The Netherlands.

    Papers in Europe PMC
  2. 02
    Stokroos RJ8 papers · 2018

    Department of Otorhinolaryngology and Head & Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.

    Papers in Europe PMC
  3. 03
    Waterval JJ8 papers · 2018

    Department of Otorhinolaryngology-Head & Neck Surgery, Maastricht University, Maastricht, The Netherlands. J.Waterval@gmail.com

    Papers in Europe PMC
  4. 04
    Huygen PL3 papers · 1992
    Papers in Europe PMC
  5. 05
    Van Hul W3 papers · 2023

    Department of Medical Genetics, University of Antwerp, Antwerp, Belgium.

    Papers in Europe PMC
  6. 06
    Borra VM2 papers · 2018

    Department of Medical Genetics, University of Antwerp, Prins Boudewijnlaan 43, Edegem, 2650, Antwerp, Belgium. vere.borra@ua.ac.be

    Papers in Europe PMC
  7. 07
    Cruysberg JR2 papers · 1990
    Papers in Europe PMC
  8. 08
    De Bondt RB2 papers · 2010
    Papers in Europe PMC
  9. 09
    Hendrickx G2 papers · 2023

    Department of Human Genetics, KU Leuven, Leuven, Belgium.

    Papers in Europe PMC
  10. 10
    Scaf JJ2 papers · 1990
    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 11 September 2026 · last trial check 11 September 2026

No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.

low confidence · 38.6th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Hyperostosis cranialis interna — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

("Hyperostosis cranialis interna" OR "hyperostosis cranalis interna" OR "hyperostosis cranialis interna (disease)") OR (MESH:"Hyperostosis Cranialis Interna") OR ("SLC39A14" OR "SLC39A14 syndrome" OR "SLC39A14-related")

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: Hyperostosis Cranialis Interna

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Hyperostosis cranialis interna" OR "hyperostosis cranalis interna" OR "hyperostosis cranialis interna (disease)"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (1683) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity

Ingested 2026-07-27T16:24:51.127Z